Mamoudou Maiga

  • 544 Citations
20072023
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

I have a broad background in molecular and clinical microbiology. My research work focuses primarily on novel treatment and diagnostic strategies for tuberculous and Non-tuberculous mycobacteria (NTM). Using animal and cellular models during my PhD training at Johns Hopkins School of Medicine, we found couple Food and Drug Administration approved drugs that could be repurposed as Host Directed Therapy to improve and reduce the duration of tuberculosis first-line treatment. Under my post-doctoral training at the NIAID, I studied the impact of tuberculosis drug treatment on gut and lung microbiota, and its subsequent consequence on host immune ability to clear remaining bacterial strains from affected organs. I am also involved in many tuberculosis clinical studies at the University of Bamako in Mali since 2007 and have served as study coordinator in many of those studies. During the last Ebola crisis, I was part of the NIAID response team in Liberia and Guinea to implement and conduct the Ebola Phase II vaccine trials. HIV drug pharmacological aspects have also been my interest. Since December 2016, I accepted a Research Assistant Professor position at Northwestern University to work on new diagnostic strategies for mycobacterial diseases at the Center for Innovation in Global Health Technologies (CIGHT) and to serve as investigator in the AIDS Clinical Trials Group (ACTG) clinical studies within the Center for Global Health. My international collaborations are primarily in Mali, Nigeria, Guinea and Liberia.

Education/Academic qualification

MD, PhD

Research interests

  • Diagnostics
  • Emerging Infectious Diseases
  • HIV
  • Host-Directed Therapy
  • Microbiome
  • Pharmacokinetics
  • Pharmacovigilance
  • Tuberculosis

Fingerprint Dive into the research topics where Mamoudou Maiga is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Mali Medicine & Life Sciences
Tuberculosis Medicine & Life Sciences
Mycobacterium tuberculosis Medicine & Life Sciences
Multidrug-Resistant Tuberculosis Medicine & Life Sciences
Breath Tests Medicine & Life Sciences
Drug Resistance Medicine & Life Sciences
Mycobacterium Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2015 2023

Microbiota
Tuberculosis
Anti-Bacterial Agents
Dysbiosis
Therapeutics
Research Personnel
Biostatistics
HIV
Organized Financing
Research Ethics Committees

Research Output 2007 2019

  • 544 Citations
  • 31 Article
  • 5 Review article
  • 1 Comment/debate
  • 1 Letter
1 Citation (Scopus)

Clinical risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in Mali

Baya, B., Achenbach, C. J., Kone, B., Toloba, Y., Dabitao, D. K., Diarra, B., Goita, D., Diabaté, S., Maiga, M., Soumare, D., Ouattara, K., Kanoute, T., Berthe, G., Kamia, Y. M., Sarro, Y. D. S., Sanogo, M., Togo, A. C. G., Dembele, B. P. P., Coulibaly, N., Kone, A. & 8 others, Akanbi, M., Belson, M., Dao, S., Orsega, S., Siddiqui, S., Doumbia, S., Murphy, R. L. & Diallo, S., Apr 1 2019, In : International Journal of Infectious Diseases. 81, p. 149-155 7 p.

Research output: Contribution to journalArticle

Open Access
Mali
Multidrug-Resistant Tuberculosis
Sputum
Treatment Failure
Drug Resistance

Competitive fitness of Mycobacterium tuberculosis in vitro

Kodio, O., Togo, A. C. G., Sarro, Y. D. S., Fane, B., Diallo, F., Somboro, A., Degoga, B., Kone, M., Coulibaly, G., Tolofoudje, M., Bane, S., Sanogo, M., Kone, B., Coulibaly, N., Dabitao, D., Baya, B., Maiga, M., Bougoudogo, F., Samake, F., Dao, S. & 3 others, Doumbia, S., Diallo, S. & Diarra, B., Jul 1 2019, In : International Journal of Mycobacteriology. 8, 3, p. 287-291 5 p.

Research output: Contribution to journalArticle

Mycobacterium tuberculosis
Cross-Sectional Studies
Bacteria
Mutation
Centers for Disease Control and Prevention (U.S.)

Differential HLA allele frequency in Mycobacterium africanum vs Mycobacterium tuberculosis in Mali

Kone, A., Diarra, B., Cohen, K., Diabate, S., Kone, B., Diakite, M. T., Diarra, H., Sanogo, M., Togo, A. C. G., Sarro, Y. D. S., Baya, B., Coulibaly, N., Kodio, O., Achenbach, C. J., Murphy, R. L., Holl, J. L., Siddiqui, S., Doumbia, S., Bishai, W. R., Diallo, S. & 1 others, Maiga, M., Jan 1 2019, In : HLA. 93, 1, p. 24-31 8 p.

Research output: Contribution to journalArticle

Mali
Mycobacterium
Mycobacterium tuberculosis
Gene Frequency
Tuberculosis

Evaluation of Two HIV Rapid Diagnostic Tests in a Context of Strains' Genetic Diversity in Mali

Togo, J., Maiga, A. I., Sylla, M., Kone, B., Dolo, O., Traore, F. T., Sangare, S. A., Maiga, M., Diallo, S., Murphy, R. L., Calvez, V. & Marcelin, A. G., Feb 1 2019, In : AIDS research and human retroviruses. 35, 2, p. 145-149 5 p.

Research output: Contribution to journalArticle

Mali
Routine Diagnostic Tests
HIV-2
HIV
Confidence Intervals
Point-of-Care Systems
HIV-1
Acquired Immunodeficiency Syndrome
HIV
Africa South of the Sahara